相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A statistical approach to boost soluble expression of E. coli-derived virus-like particles in shake-flask cultivation
Nhat Hoang Huynh et al.
JOURNAL OF BIOTECHNOLOGY (2022)
A review on corona virus disease 2019 (COVID-19): current progress, clinical features and bioanalytical diagnostic methods
Fariba Mollarasouli et al.
MICROCHIMICA ACTA (2022)
In vitro assembly of chimeric virus-like particles composed of a porcine circovirus 2b capsid protein and a B-cell epitope of infectious bursal disease virus
Xiaomeng Sun et al.
BIOTECHNOLOGY LETTERS (2022)
Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice
Challika Kaewborisuth et al.
VACCINES (2022)
Development of virus-like particles-based vaccines against coronaviruses
Chean Yeah Yong et al.
BIOTECHNOLOGY PROGRESS (2022)
A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants
Ching-Wen Chang et al.
VIRUSES-BASEL (2022)
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
Ting Y. Wong et al.
MSPHERE (2022)
Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them
Maryam Zamani Sani et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain
Xinyue Chang et al.
VACCINES (2021)
Immunogenicity and Vaccine Efficacy Boosted by Engineering Human Heavy Chain Ferritin and Chimeric Hepatitis B Virus Core Nanoparticles
Yiran Qu et al.
ACS APPLIED BIO MATERIALS (2021)
An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis
Sebastian Aston-Deaville et al.
VACCINE (2020)
Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach
Anam Naz et al.
FRONTIERS IN IMMUNOLOGY (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate
Yao Lei et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Chimeric hepatitis B virus core particles displaying Neisserial surface protein A confer protection against virulent Neisseria meningitidis serogroup B in BALB/c mice
YongLi Hou et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
IgG and IgM responses to human papillomavirus L1 virus-like particle as a function of dosing schedule and vaccine formulation
Min-Hye Park et al.
JOURNAL OF MICROBIOLOGY (2019)
Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice
Jingjing Guo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Escherichia coli-derived virus-like particles in vaccine development
Xiaofen Huang et al.
NPJ VACCINES (2017)
Yield Optimisation of Hepatitis B Virus Core Particles in E-coli Expression System for Drug Delivery Applications
Izzat Fahimuddin Bin Mohamed Suffian et al.
SCIENTIFIC REPORTS (2017)
Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery
Marcus J. Rohovie et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2017)
Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection
Lei Qiao et al.
ANTIVIRAL RESEARCH (2016)
The application of virus-like particles as vaccines and biological vehicles
Dan Yan et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Tandem Fusion of Hepatitis B Core Antigen Allows Assembly of Virus-Like Particles in Bacteria and Plants with Enhanced Capacity to Accommodate Foreign Proteins
Hadrien Peyret et al.
PLOS ONE (2015)
Production and applications of engineered viral capsids
Jeff Glasgow et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Bioengineering Virus-Like Particles as Vaccines
Linda H. L. Lua et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Chimeric Virus-Like Particle Vaccines Displaying Conserved Enterovirus 71 Epitopes Elicit Protective Neutralizing Antibodies in Mice through Divergent Mechanisms
Xiaohua Ye et al.
JOURNAL OF VIROLOGY (2014)
Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles
Dace Skrastina et al.
PLOS ONE (2014)
Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development
William A. Rodriguez-Limas et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Hepatitis B core-based virus-like particles to present heterologous epitopes
Kenny Roose et al.
EXPERT REVIEW OF VACCINES (2013)
Construction and Characterization of Virus-Like Particles: A Review
Andris Zeltins
MOLECULAR BIOTECHNOLOGY (2013)
A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles
Elena A. Blokhina et al.
VIROLOGY (2013)
Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV
Yong-shan Wang et al.
VACCINE (2012)
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
Anton P. J. Middelberg et al.
VACCINE (2011)
Microbial production of virus-like particle vaccine protein at gram-per-litre levels
Mervyn W. O. Liew et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent
PK Hsieh et al.
JOURNAL OF VIROLOGY (2005)
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant montanide ISA 720 in a phase I trial
GA Oliveira et al.
INFECTION AND IMMUNITY (2005)
A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts
A Birkett et al.
INFECTION AND IMMUNITY (2002)
HBV core particles as a carrier for B cell/T cell epitopes
P Pumpens et al.
INTERVIROLOGY (2001)
分享论文
